Syngene International acquires assets of Strand Life Sciences

22 Sep 2016 Evaluate

Syngene International, Asia’s leading Contract Research Organization, has completed a deal through which it has purchased assets of Strand Life Sciences related to systems biology, Heptox and pharma bioinformatics services. This includes target dossier business and rights to NGS data analytics and Sarchitect platforms, supported by a strong scientific team. This deal gives Syngene access to Strand’s patented Virtual Liver model and the NGS analytics platform.

Syngene International is one of Asia’s largest Contract Research Organizations, offers discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition.



Syngene Internation. Share Price

683.25 9.10 (1.35%)
18-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 683.25
Sagility India 42.29
AGS Transact Tech 11.46
Just Dial 837.00
Krystal Integrated 428.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...